Home/Filings/4/0001013237-22-000070
4//SEC Filing

Fernandez Gene D. 4

Accession 0001013237-22-000070

CIK 0001013237other

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 4:37 PM ET

Size

24.4 KB

Accession

0001013237-22-000070

Insider Transaction Report

Form 4
Period: 2022-04-07
Transactions
  • Sale

    Common Stock

    2022-04-07$441.64/sh4,245$1,874,7626,122 total
  • Sale

    Common Stock

    2022-04-07$443.85/sh2,100$932,0851,001 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2022-04-0712,2903,073 total
    Exercise: $192.11Exp: 2027-12-22Common Stock (12,290 underlying)
  • Sale

    Common Stock

    2022-04-07$445.39/sh7$3,11812,290 total
  • Sale

    Common Stock

    2022-04-07$444.73/sh700$311,311301 total
  • Exercise/Conversion

    Common Stock

    2022-04-07$221.88/sh+4,227$937,8874,227 total
  • Sale

    Common Stock

    2022-04-07$444.62/sh4,220$1,876,29612,297 total
  • Sale

    Common Stock

    2022-04-07$442.67/sh3,021$1,337,3063,101 total
  • Exercise/Conversion

    Common Stock

    2022-04-07$192.11/sh+12,290$2,361,03216,517 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2022-04-074,2272,818 total
    Exercise: $221.88Exp: 2028-11-01Common Stock (4,227 underlying)
  • Sale

    Common Stock

    2022-04-07$445.57/sh301$134,1170 total
  • Sale

    Common Stock

    2022-04-07$440.90/sh1,923$847,85110,367 total
Footnotes (9)
  • [F1]This transaction was executed in multiple trades with sales prices ranging from $444.31 to $445.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed in multiple trades with sales prices ranging from $440.17 to $441.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades with sales prices ranging from $441.22 to $442.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades with sales prices ranging from $442.25 to $443.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]This transaction was executed in multiple trades with sales prices ranging from $443.32 to $444.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F6]This transaction was executed in multiple trades with sales prices ranging from $444.32 to $445.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F7]This transaction was executed in multiple trades with sales prices ranging from $445.54 to $445.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F8]Options granted on November 1, 2018 vest 20% annually on the anniversary date of the grant and are fully vested after five years.
  • [F9]Options granted on December 22, 2017 vest 20% annually on the anniversary date of the grant and are fully vested after five years.

Issuer

FACTSET RESEARCH SYSTEMS INC

CIK 0001013237

Entity typeother

Related Parties

1
  • filerCIK 0001723733

Filing Metadata

Form type
4
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:37 PM ET
Size
24.4 KB